Dear All,
I am working for the Technology Strategy Board overseeing all technical aspects of their Innovation Platform on the Detection and Identification of Infectious Agents (one pager attached). As part of my scanning exercise I am interested in rapid/POC devices already in use in the
HAI - in particular MRSA, c.difficile and community acquired pneumonia
TB (latent and active)
Sepsis
STIs (Chlamydia and Gonorrhea).
As you're aware, antimicrobial resistance is an area of great concern so that technologies that help to reduce the inappropriate use of antibiotics - through, for example, distinguishing between viral and bacterial infections, are also of interest.
In addition to the above and separate to the Innovation Platform, I am interested in the possibility of using POC/rapid tests to screen pregnant woman for infectious diseases - currently rubella antibody, HIV, HepB and syphillis are assessed. Again I should be grateful for information on any hospitals or centres that are using POC/rapid tests to measure any of these analytes.
All comments welcome, I'm aware that for some of the anaytes POC tests aren't on the market and that for others there are some "less than desirable" tests around.
If you are a developer in this area please let me know and I will ensure that you are in our database for being invited to our workshops (in order to receive support for the Technology Stategy Board you must be a
My Technology Strategy Board contact details are:-
Dr Penny Wilson
Lead Specialist Detection and Identification of Infectious Agents
Technology Strategy Board
Block B,
North Star Avenue
Switch: +44 (0)1793 442700
Kind Regards,
Penny
Dr Penny Wilson
Director BioZenix Ltd
+44 7967 560171